Related references
Note: Only part of the references are listed.Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious
Mark D. Muthiah et al.
HEPATOLOGY INTERNATIONAL (2020)
Hepatitis B Immunoglobulin discontinuation in long-term liver transplant patients
Eva Maria Dobrindt et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
Gil-Chun Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Liver transplantation for Hepatitis-B-associated liver disease - Three decades of experience
Eva Maria Teegen et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety
Samar K. Darweesh et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Cost Analysis and Determinants of Living Donor Liver Transplantation in Taiwan
L. -M. Lin et al.
TRANSPLANTATION PROCEEDINGS (2018)
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients
Tokunbo Ajayi et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2018)
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study
Scott Fung et al.
JOURNAL OF HEPATOLOGY (2017)
Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis
Ji-Na Zheng et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
Paolo De Simone et al.
TRANSPLANTATION (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
N. S. Choudhary et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
Bruno Roche et al.
TRANSPLANTATION (2015)
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Peijie Wang et al.
PLOS ONE (2014)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Antiviral treatment for hepatitis B virus recurrence following liver transplantation
Sanghoon Lee et al.
CLINICAL TRANSPLANTATION (2013)
HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience
Chun-Hui Yuan et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2013)
Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs
J. Peveling-Oberhag et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation
Lewis W. Teperman et al.
LIVER TRANSPLANTATION (2013)
Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin
Joseph Ahn et al.
Hepatitis Monthly (2012)
The option of HBIG-free prophylaxis against recurrent HBV
Alyson N. Fox et al.
JOURNAL OF HEPATOLOGY (2012)
Liver Transplantation in Delta Virus Infection
Bruno Roche et al.
SEMINARS IN LIVER DISEASE (2012)
Posttransplantation Prophylaxis With Primary High-Dose Hepatitis B Immunoglobulin Monotherapy and Complementary Preemptive Antiviral Add-On
Shin Hwang et al.
LIVER TRANSPLANTATION (2011)
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
Isabel Campos-Varela et al.
ANNALS OF HEPATOLOGY (2011)
Hepatitis B virus infection and liver transplantation
Melissa Kennedy et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2010)
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis
L. H. Katz et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Outcomes of Long-Term Administration of Intravenous Hepatitis B Immunoglobulins for the Prevention of Recurrent Hepatitis B After Liver Transplantation
K. Pauwelyn et al.
TRANSPLANTATION PROCEEDINGS (2010)
Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis
Wensheng Rao et al.
TRANSPLANT INTERNATIONAL (2009)
Predictive Factors of Outcome in Patients Transplanted for Hepatitis B
Susanne Beckebaum et al.
TRANSPLANTATION (2009)
Hepatitis B immunoglobulin and lamivudine improve hepatitis B-related outcomes after liver transplantation: Meta-analysis
Rohit Loomba et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis
Peter W. Angus et al.
HEPATOLOGY (2008)
Viral persistence after liver transplantation for hepatitis B virus: A cross-sectional study
Dennis A. Freshwater et al.
TRANSPLANTATION (2008)
Liver transplantation for hepatitis B virus patients: Long-term results of three therapeutic approaches
A. W. Avolio et al.
TRANSPLANTATION PROCEEDINGS (2008)
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years
Nevin Yilmaz et al.
LIVER INTERNATIONAL (2008)
Adherence to lamivudine after an early withdrawal of hepatitis B immune. globulin plays an important role in the long-term prevention of hepatitis B virus recurrence
Maria Buti et al.
TRANSPLANTATION (2007)
Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen
Z.-Y. Jiao et al.
TRANSPLANTATION PROCEEDINGS (2007)
Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection
Lucio Caccamo et al.
TRANSPLANTATION (2007)
Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection
Hideo Yoshida et al.
CLINICAL TRANSPLANTATION (2007)
Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy
Stephen N. Wong et al.
LIVER TRANSPLANTATION (2007)
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation
Nam-Joon Yi et al.
LIVER TRANSPLANTATION (2007)
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results
Eugene Schiff et al.
LIVER TRANSPLANTATION (2007)
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis
SS Zheng et al.
LIVER TRANSPLANTATION (2006)
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine
CM Lo et al.
LIVER TRANSPLANTATION (2005)
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
A Marzano et al.
LIVER TRANSPLANTATION (2005)
Outcomes in liver transplant recipients with hepatitis B virus: Resistance and recurrence patterns from a large transplant center over the last decade
GW Neff et al.
LIVER TRANSPLANTATION (2004)
Prevention of hepatitis B virus reinfection after orthotopic liver transplantation
ZX Wang et al.
TRANSPLANTATION PROCEEDINGS (2004)
Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection
FG Villamil
JOURNAL OF HEPATOLOGY (2003)
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: Long-term results
J Dumortier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis
B Roche et al.
HEPATOLOGY (2003)
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
M Buti et al.
JOURNAL OF HEPATOLOGY (2003)
Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature
Z Ben-Ari et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation
JM Sousa et al.
TRANSPLANTATION PROCEEDINGS (2003)
Is lamivudine with 1-week HBIg as effective as long-term high-dose HBIg in HBV prophylaxis after liver transplantation?
SJ Park et al.
TRANSPLANTATION PROCEEDINGS (2002)
New era of liver transplantation for hepatitis B - A 17-year single-center experience
DM Anselmo et al.
ANNALS OF SURGERY (2002)
Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine
KW Lee et al.
TRANSPLANTATION PROCEEDINGS (2001)
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation
D Seehofer et al.
TRANSPLANTATION (2001)
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
NV Naoumov et al.
JOURNAL OF HEPATOLOGY (2001)
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis
A Marzano et al.
JOURNAL OF HEPATOLOGY (2001)
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
SHB Han et al.
LIVER TRANSPLANTATION (2000)
Share Paper
